Expression of myostatin pro domain results in muscular transgenic mice
Citations Over TimeTop 12% of 2001 papers
Abstract
Myostatin, a member of the TGF-beta family, negatively regulates skeletal muscle development. Depression of myostatin activity leads to increased muscle growth and carcass lean yield. In an attempt to down-regulate myostatin, transgenic mice were produced with a ribozyme-based construct or a myostatin pro domain construct. Though the expression of the ribozyme was detected, muscle development was not altered by the ribozyme transgene. However, a dramatic muscling phenotype was observed in transgenic mice carrying the myostatin pro domain gene. Expression of the pro domain transgene at 5% of beta-actin mRNA levels resulted in a 17-30% increase in body weight (P 0.05). Thus, the muscular phenotype is attributable to myofiber hypertrophy rather than hyperplasia. The results of this study suggest that the over-expression of myostatin pro domain may provide an alternative to myostatin knockouts as a means of increasing muscle mass in other mammals.
Related Papers
- → Dominant negative myostatin produces hypertrophy without hyperplasia in muscle(2000)228 cited
- → A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle(2002)91 cited
- → p21-Activated Kinase 1 Is Permissive for the Skeletal Muscle Hypertrophy Induced by Myostatin Inhibition(2021)4 cited
- → Effect Of Phytoecdysteroid Supplementation On Myostatin Mrna Expression In Aged Murine Skeletal Muscle Tissue(2018)
- → Abstract 1432: Cardiomyocyte Myostatin Contributes to Skeletal Muscle Wasting in Heart Failure(2008)